Conference abstract · 23 Jun 2025
Conference abstractPublished 5 Sep 2011
Drug combination strategies in viral therapy using the Combination-Index Theorem
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Drug combination has been widely used for the treatment of cancer and AIDS. However, there are about 20 diff erent defi nitions for synergism but none supported the others (Chou TC, Pharmacol. Rev. 58: 621-681, 2006; free web link: http://pharmrev.aspetjournals.org/cgi/reprint/58/3/621). Th e confusion on synergy defi nition have infl icted serious tolls in eff orts, time and resources in biomedical research. Th e combination index (CI) theorem based on the median-eff ect principle of the mass-action law has been widely used for computerized drug combination studies. One article by Chou TC and Talalay P (Adv. Enz. Regul. 22: 27-55, 1984) alone, has been cited 2,351 times in 479 journals (www.researcherid.com/rid/B-4111-2009). However, not all researchers fully understand its theoretical basis and its fl exible applications. Th is author has published 49 articles on drug combinations against HIV, HSV and CMV using the CI method. Th is paper will illustrate the experimental design, computerized simulation for quantitatively determining synergism (CI 1) using the Fa-CI plot (Chou-Talalay plot) or the isobolograms. Th e dose-reduction index (DRI) signifi es how many folds of dose-reduction for each drug at a given eff ect are allowed in synergistic combination. DRI projects the reduced toxicity toward the host. In addition, how to effi ciently pick the proper combination cocktails for maximal synergy will be demonstrated with Chou?s ?polygonogram?. Two clinical trials, AZT + 3TC (366 patients, using statistical calculations) and AZT +IFNα (36 patients, using the CI method) are compared. It is demonstrated that in AZT + 3TC trials with p<0.001, did not prove synergy, whereas in AZT + IFNα proved synergy (CI<1). It is concluded that the median-eff ect principle and the CI theorem are effi cient, quantitative and econo-green approach for the biomedical research, including the drug combination strategies in viral therapy.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Antivirals & Antiretrovirals.
Conference abstract · 23 Jun 2025
Exploring signature proteins to design a novel multi-epitope vaccine candidate against Mycobacterium tuberculosis: An in-silico approach
Conference abstract · 23 Jun 2025
Correlation Between the Rh/ABO system and infection due to sars cov2 in morocco
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Antivirals & Antiretrovirals
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Ting-Chao Chou”
